Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (23)

2024

  1. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 711-723

  2. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

    Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962

  3. T-cell immune profile in blood of systemic mastocytosis: Association with disease features

    Allergy: European Journal of Allergy and Clinical Immunology

2023

  1. Automated EuroFlow approach for standardized in-depth dissection of human circulating B-cells and plasma cells

    Frontiers in Immunology, Vol. 14

  2. Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study

    Blood Cancer Journal

  3. Bone and Cytokine Markers Associated With Bone Disease in Systemic Mastocytosis

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 5, pp. 1536-1547

  4. Clinical, Histopathologic and Genetic Features of Rhabdoid Meningiomas

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  5. High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients

    Blood, Vol. 141, Núm. 3, pp. 309-314

  6. Immune cell kinetics and antibody response in COVID-19 patients with low-count monoclonal B-cell lymphocytosis

    American Journal of Hematology, Vol. 98, Núm. 12, pp. 1909-1922

  7. Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study

    Blood Cancer Journal, Vol. 13, Núm. 1

  8. In-depth blood immune profiling of Good syndrome patients

    Frontiers in Immunology, Vol. 14

  9. KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1347-1359

  10. Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil

    Cancers, Vol. 15, Núm. 5

  11. Lymphocytic variant hypereosinophilic syndrome successfully treated with hematopoietic stem cell transplantation: A treatment challenge

    Pediatric Blood and Cancer

  12. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality

    The journal of allergy and clinical immunology. In practice, Vol. 11, Núm. 3, pp. 908-919

  13. Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study

    Cytometry Part B - Clinical Cytometry

  14. Predominantly Pro-Inflammatory Phenotype with Mixed M1/M2 Polarization of Peripheral Blood Classical Monocytes and Monocyte-Derived Macrophages among Patients with Excessive Ethanol Intake

    Antioxidants, Vol. 12, Núm. 9

  15. Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper from an Ad Hoc International Expert Panel

    HemaSphere, Vol. 7, Núm. 3, pp. E841

2022

  1. Altered innate immune profile in blood of systemic mastocytosis patients

    Clinical and Translational Allergy, Vol. 12, Núm. 6

  2. Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis

    Cancers, Vol. 14, Núm. 10